Posted May 13, 2021
While vaccine debates make for great political fodder, the bottom line is that most of us are alive today because of vaccines. And in the case of messenger RNA vaccines, this is just the next evolution of vaccine science — and an amazing opportunity for investors to make a lot of money.
Posted May 12, 2021
In addition to the current fuel shortages, there are some things you need to know. Energy and Capital editor Keith Kohl reveals the bigger story that investors aren't being told about the Colonial Pipeline cyberattack.
Posted May 11, 2021
How do you get the big winners in biotech? You play the FDA approval system. Energy and Capital editor Christian DeHaemer discusses how retail investors can utilize "Phase 3 rocket shots" and get the most from the biotech market...
Posted May 7, 2021
Cryptocurrency super-spikes can deliver life-changing gains. We've seen it time and time again over the past few years. Today, market analyst Sean McCloskey reveals why BTC is headed for $125,000 and discusses what other alt-coins could offer even bigger gains.
Posted May 6, 2021
While market analyst Jeff Siegel has certainly taken advice from the Oracle of Omaha over the years, he’s also been very conscious of the fact that there’s more than one way to make a buck. And it doesn’t always have to be “Warren’s way.”
Posted May 5, 2021
For the first time in market history, the market cap of a renewable energy company briefly surpassed that of the mighty ExxonMobil. Market analyst Keith Kohl looks at the biggest winners in Biden's energy future...
Posted May 4, 2021
The digital twin market is booming. It is used in the aerospace and defense, automotive and transportation, and healthcare sectors, among others. And as an investor, you want to be a part of it.
Posted May 3, 2021
It all went down on April 6… Wyoming Gov. Mark Gordon created a $1.2 million fund that would be used to help the state’s coal industry sue any state that blocks its coal exports.
Posted April 30, 2021
Bitcoin is going to hit over $100,000 per coin in the next few years. Today, market analyst Sean McCloskey explains exactly how and when, and what will happen if you fail to act before it happens.
Posted April 29, 2021
While investors in both Bionomics and IntelGenx have seen double-digit gains in just the past week, there are three more psychedelics stocks that are poised to get a big pop within the next three weeks...
Posted April 28, 2021
Energy and Capital editor Keith Kohl peels back the curtain behind President Biden's ambitious plans to transform the U.S. energy sector.
Posted April 23, 2021
In 2020, there were 37 billion data breaches on the internet. The very backbone of our information superhighway is broken and needs a major overhaul. Today, analyst Sean McCloskey shows how it will happen.
Posted April 22, 2021
Although the psychedelics market is still very young, it is absolutely going to usher in one of the most disruptive waves of innovation the mental health industry has seen in decades. And right now, atai is the 800-pound gorilla in the psychedelics space.
Posted April 20, 2021
Coinbase has 36 million shares in the float — that is, shares tradable by you and me now — but it has 199 million shares outstanding, which will be tradable in the future. This future float will drive down the share price at which point you can buy it as an investment at the lows.
Posted April 19, 2021
Could this be the end of America's oil empire? Market analyst Keith Kohl discusses why Biden’s next move will most assuredly determine the winners and losers of the U.S. oil industry...